drugset / Trial / NCT04301804
A Trial of SHR6390 in Healthy Caucasian Volunteers
RandomizedParallel-groupOpen-labelOther
Summary
This is a Phase 1, single center, single dose, open-label clinical study to evaluate the pharmacokinetics, safety and tolerability of SHR6390 under fasting conditions in healthy caucasian volunteers
Timeline
- Start
- 2020-03-12
- Primary completion
- 2020-05-28
- Completion
- 2020-09-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dalpiciclib | Small molecule | — | Oral |
Indications
No indication recorded.